IMV
CSLB Exam Prep – Practice Tests, Study Guides & Exam Preparation
IMV was founded in 2007, is headquartered in Halifax, Canada, lists 51–200 employees, and has $26.7M in recorded funding across 1 round.
- Headquarters
- Halifax
- Employees
- 51–200
- Founded
- 2007
- Website
- imv-inc.com
- Total Funding
- $26.7M
- Last Round
- $26.7M Venture RoundMar 2019
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 1 funding round for this company. The full record is or through the API.
About
IMV Inc. is a clinical-stage immuno-oncology company developing a portfolio of therapies based on its proprietary DPX® immune-educating platform. The company's lead candidate maveropepimut-S (MVP-S) targets survivin, a cancer antigen overexpressed in advanced cancers, and is being evaluated in clinical trials for DLBCL, ovarian, bladder, and breast cancers.
Summary
IMV is a Biotech company based in Halifax, Canada, founded in 2007. It lists 51–200 employees. It has raised $26.7M in total across 1 round, most recently a $26.7M Venture Round in Mar 2019.
Tech & App Stack
4 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Mar 2019
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/imv"><img src="https://indexed.vc/api/badge/company/imv" alt="IMV on Indexed.vc" width="260" height="76" /></a>